Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VESPER: GC vs HD-MVAC in Perioperative Bladder Cancer
NCT01812369Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Feb 2013
- Primary completion
- Sep 2023
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of methotrexate, vinblastine, doxorubicin, cisplatin in bladder cancer, sponsored by Rouen University Hospital. Started Feb 2013; status: completed.
02
Drugs
methotrexatevinblastinedoxorubicincisplatin
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT01812369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812369.